Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.21 | N/A | -51.39% |
management commentary, guidance changes, and full analysis available with Pro.
| -51.39% |
Tone: Defensive
Overall, management conveyed a cautious outlook, recognizing the impact of current market conditions on performance.
Management acknowledged the challenges faced in the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.
Boston Scientific's earnings report indicates a significant miss on EPS, which may raise concerns among investors about the company's short-term performance. The stock's slight decline of 0.02% reflects this disappointment. Management's defensive tone suggests they are aware of the challenges ahead but remain focused on long-term strategies.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMERIPRISE FINL INC
Apr 24, 2023